US7157267B2ExpiredUtilityA1
Secreted and transmembrane polypeptides and nucleic acids encoding the same
Est. expiryOct 17, 2017(expired)· nominal 20-yr term from priority
C07K 14/47
76
PatentIndex Score
1
Cited by
35
References
6
Claims
Abstract
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Claims
exact text as granted — not AI-modified1. The isolated nucleic acid encoding a polypeptide having at least 95% sequence identity to:
(a) the amino acid sequence of the polypeptide of SEQ ID NO:2;
(b) the amino acid sequence of the polypeptide of SEQ ID NO:2, lacking its associated signal peptide;
(c) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:1; or
(d) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209375;
wherein said polypeptide inhibits endothelial cell growth.
2. The isolated nucleic acid of claim 1 encoding a polypeptide having at least 99% sequence identity to:
(a) the amino acid sequence of the polypeptide of SEQ ID NO:2;
(b) the amino acid sequence of the polypeptide of SEQ ID NO:2, lacking its associated signal peptide;
(c) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:1; or
(d) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number 209375;
wherein said polypeptide inhibits endothelial cell growth.
3. A vector comprising the nucleic acid of claim 1 .
4. The vector of claim 3 , wherein said nucleic acid is operably linked to control sequences recognized by a host cell transformed with the vector.
5. A host cell comprising the vector of claim 4 .
6. The host cell of claim 5 , wherein said cell is a CHO cell, an E. coli or a yeast cell.Join the waitlist — get patent alerts
Track US7157267B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.